期刊
DIGESTIVE AND LIVER DISEASE
卷 40, 期 -, 页码 S225-S228出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1590-8658(08)60530-7
关键词
Crohn's disease; Inflammatory bowel disease; Infliximab; Ulcerative colitis
资金
- Italian Ministry of Health [72]
The pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) plays a central role in mucosal inflammation and is a key mediator in the inflammatory cascade in both Crohn's disease (CD) and ulcerative colitis (UC). Infliximab, a monoclonal antibody against TNF-alpha has been proved highly effective in the clinical management of both forms of IBD. Aim of this paper is to review the mechanisms of action of infliximab in IBD. (c) 2008 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据